DISCOUNT OPTIONSSCHEIN - IDEXX LABORATORIES Share Price

Certificat

DE000ME545M0

Real-time Bid/Ask 16:26:24 17/06/2024 BST
0.41 EUR / 0.79 EUR +33.33% Intraday chart for DISCOUNT OPTIONSSCHEIN - IDEXX LABORATORIES
Current month-8.16%
1 month-43.75%
Date Price Change
17/06/24 0.43 -4.44%
14/06/24 0.45 +4.65%
13/06/24 0.43 -21.82%
12/06/24 0.55 -8.33%
11/06/24 0.6 -6.25%

Delayed Quote Börse Stuttgart

Last update June 17, 2024 at 01:22 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying IDEXX LABORATORIES, INC.
Issuer Morgan Stanley
WKN ME545M
ISINDE000ME545M0
Date issued 12/12/2023
Strike 650 $
Maturity 20/12/2024 (186 Days)
Parity 10 : 1
Emission price 1.09
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.91
Lowest since issue 0.41
Spread 0.38
Spread %48.10%

Company Profile

IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Sector
-
More about the company

Ratings for IDEXX Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: IDEXX Laboratories, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
504 USD
Average target price
565.1 USD
Spread / Average Target
+12.11%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW